Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Diagnosis of Adenoid Cystic Carcinoma on 68Ga-PSMA-617 PET-CT and Therapy With 177Lu-EB-PSMA-617

Next Previous
X
Search
Trial Profile

Diagnosis of Adenoid Cystic Carcinoma on 68Ga-PSMA-617 PET-CT and Therapy With 177Lu-EB-PSMA-617

Status: Recruiting
Phase of Trial: Phase 0

Latest Information Update: 06 Mar 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Gallium (68Ga) gozetotide (Primary) ; Fludeoxyglucose F-18; Lutetium (177Lu) vipivotide tetraxetan
  • Indications Adenoid cystic carcinoma
  • Focus Diagnostic use

    • Most Recent Events

    • 22 Mar 2021 New trial record
    • 18 Mar 2021 Number of treatment arms is reduced from 2 to 1, by removing an Experimental: 68Ga-PSMA, PET/CT arm. Hence, the study becomes single-arm, and thus a randomized allocation is no longer required.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top